Tissue and Plasma Biomarkers of Lymph Node Involvement in Cervical Cancer

Trial ID or NCT#

NCT01546363

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of this study is to measure the levels of serum proteins and other biomarkers in cervical cancer patients. We believe that some of these markers may be useful in selecting patients for specific types of cancer therapies. These markers may also help to predict response to therapy, relapse after therapy, and survival after therapy.

Official Title

Tissue and Plasma Biomarkers of Lymph Node Involvement in Cervical Cancer

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

Jonathan S. Berek, MD, MMSc
Jonathan S. Berek, MD, MMSc
Gynecologic oncologist
Laurie Kraus Lacob Professor
Nelson Teng
Elizabeth A Kidd
Elizabeth A Kidd
Radiation oncologist
Professor of Radiation Oncology (Radiation Therapy)

Contact us to find out if this trial is right for you.

Contact

Dylann Fujimoto
650-723-8843

View on ClinicalTrials.gov